Intellia Therapeutics Inc (NASDAQ:NTLA)

11.96
Delayed Data
As of Apr 03
 +0.06 / +0.50%
Today’s Change
9.18
Today|||52-Week Range
19.00
-18.47%
Year-to-Date
Is CRISPR Therapeutics Stock a Buy?
8:07am / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close11.90
Today’s open11.86
Day’s range11.56 - 12.10
Volume29,451
Average volume (3 months)718,236
Market cap$598.5M
Data as of 4:00pm ET, 04/03/2020

Growth & Valuation

Earnings growth (last year)-6.31%
Earnings growth (this year)-20.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+41.63%
P/E ratioNM
Price/Sales16.08
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
TLRYTilray Inc-0.60-9.84%
CARACara Therapeutics In...+0.09+0.71%
IMGNImmunoGen Inc-0.05-1.44%
KDMNKadmon Holdings Inc-0.16-4.15%
Data as of 4:01pm ET, 04/03/2020

Financials

Next reporting dateMay 5, 2020
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$43.1M
Annual profit (last year)-$99.5M
Net profit margin-230.92%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts